1/22, 12:32 PM (Source: TeleTrader)
more TeleTrader news

J&J's EPS soar 33.9% to $1.5 in Q4

Johnson & Johnson said on Tuesday its sales for the fourth quarter of 2019 amounted to $20.7 billion, marking a 1.7% increase from the same period in 2018 but landing slightly below market estimates. Diluted GAAP earnings per share surged 33.9% year on year to $1.50 in the three-month period, while GAAP net income jumped 31.8% to $4 billion. Meanwhile, adjusted EPS stood at $1.88, dropping 4.6% on an annual basis.

In the whole fiscal 2019, J&J's sales amounted to $82.1 billion, up 0.6% from 2018, and diluted GAAP EPS grew by 0.4% to $5.63. Net income in the twelve-month period stood dipped 1.2% to $15.1 billion.

"We delivered strong underlying sales and earnings growth in 2019, driven by the strength of our Pharmaceutical business, accelerating performance in our Medical Devices business and improved profitability in our Consumer business," CEO Alex Gorsky stated.

J&J shares were down 0.13% following the announcement of the results.

Breaking the News / NP